Dr. Nancy Said Hernandez, DO

Dr. Hernandez practices at DaVita Bastanchury Dialysis in Fullerton, California.

Dr. Hernandez's NPI, 1831305879, was assigned on May 15, 2007. Dr. Hernandez holds California license 20A9829.

Dr. Hernandez's primary practice is DaVita Bastanchury Dialysis, at 1950 Sunnycrest Drive Suite 1300, Fullerton, CA 92835 in Orange County. The practice phone is (714) 578-0015.

Dr. Hernandez's primary practice is DaVita Bastanchury Dialysis in Fullerton, California. Dr. Hernandez is also affiliated with Providence St. Jude Medical Center. The medical group on file is Southern California Kidney Consultants. Dmand AI also links Dr. Hernandez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hernandez practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hernandez's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hernandez is board certified in nephrology by the American Board of Internal Medicine. Dr. Hernandez is licensed in California.

Dmand AI lists chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Hernandez treats.

CMS data shows 2,870 Medicare services from Dr. Hernandez across 12 procedure codes in 2024, for 483 Medicare patients. Medicare paid $249,443 for them.

CMS counts 483 Medicare patients who saw Dr. Hernandez in 2024. The largest group is 75 to 84, with 169 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 4.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hernandez's median patient age at 73, with 49% women.

In 2024, Dr. Hernandez wrote 2,047 Medicare Part D claims for 303 patients. 82% of them were for generic drugs. CMS names the drug for 1,798 of them, across 46 drugs with 11 or more claims each, at $250,169 in total drug cost. In 2023, CMS named 1,570 claims across 41 drugs.

Dr. Hernandez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hernandez as offering telehealth.

Dmand AI links Dr. Hernandez to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Renal Insufficiency, Chronic, Kidney Failure, Chronic and Renal Insufficiency. GlaxoSmithKline sponsors the most, 2.

CMS Open Payments shows 100 general payments to Dr. Hernandez from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $1,604.

Dr. Hernandez is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.